JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 40 No. 1 150-158
© 1999 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kushner, S. A.
Right arrow Articles by Kung, H. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kushner, S. A.
Right arrow Articles by Kung, H. F.

Kinetic Modeling of [99mTc]TRODAT-1: A Dopamine Transporter Imaging Agent

Steven A. Kushner, William T. McElgin, Mei-Ping Kung, P. David Mozley, Karl Plössl, Sanath K. Meegalla, Mu Mu, Stefan Dresel, Janet M. Vessotskie, Nedra Lexow and Hank F. Kung

Departments of Radiology and Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania

Correspondence: For correspondence or reprints contact: Hank F. Kung, PhD, Department of Radiology, University of Pennsylvania, 3700 Market St., Room 305, Philadelphia, PA 19104.

ABSTRACT

[99mTc]Technetium[2-[[2-[[[3-(4-chlorophenyl)8-methyl-8-azabicyclo [3.2.1] oct-2-yl]-methyl] (2-mercaptoethyl) amino] ethyl] amino] ethane-thiolato(3-)-N2,N2',S2,S2']oxo-[1R-(exo-exo)] ([99mTc] TRODAT-1) is a useful imaging agent for central nervous system dopamine transporters. The purpose of this study was to characterize the in vivo binding potential and kinetic rate constants of this agent in nonhuman primates. Methods: A series of four SPECT scans were performed on each of two female baboons with a bolus injection of [99mTc]TRODAT-1 (717 ± 78 MBq; 19.38 ± 2.12 mCi). Dynamic images of the brain were acquired over 4 h using a triple-head camera equipped with fan-beam collimators. Arterial and venous blood were sampled frequently using a peristaltic pump throughout the duration of the study. Regions of interest were drawn on the corresponding MRI scan to which each functional image was coregistered. Using analytical solutions to the three-compartment model with the Levenberg-Marquardt minimization technique, each study was individually fitted to a kinetic parameter vector (method I). Additionally, within each subject, three corresponding intrasubject studies were fitted simultaneously to a single parameter vector by constraining the binding potential, distribution volume and dissociation rate constant to improve the identifiability of the parameter estimates (method II). Results: The results clearly indicated that [99mTc] TRODAT-1 localized in the striatum with slower washout rate than other brain regions. A maximal target/nontarget ratio of 3.5 between striatum and cerebellum was obtained. SPECT image analysis of the striatum yielded unconstrained k3/k4 values of 3.4 ± 1.4, 2.4 ± 0.7, 3.0 ± 1.5, and 4.0 ± 10.3, with respective constrained (fixed k4) values of 2.9 ± 0.4, 2.4 ± 0.4, 1.7 ± 0.4 and 1.8 ± 0.4 in one baboon using method I. With method II, the corresponding simultaneously fitted values were 2.1 ± 0.3 using no constraints and 2.2 ± 0.2 using a fixed k4. The second baboon had similar results. Conclusion: These findings suggest that the binding potential and corresponding kinetic rate constants can be reliably estimated in nonhuman primates with dynamic SPECT imaging of the dopamine transporter using a technetium-based tropane analogue. Furthermore, method II parameter vectors compare favorably to those produced using method I based on SEEs.

Key Words: striatum • SPECT • dopamine neuron • Parkinson's disease




This article has been cited by other articles:


Home page
JNMHome page
W. J. Hwang, W. J. Yao, S. P. Wey, and G. Ting
Reproducibility of 99mTc-TRODAT-1 SPECT Measurement of Dopamine Transporters in Parkinson's Disease
J. Nucl. Med., February 1, 2004; 45(2): 207 - 213.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1999 by the Society of Nuclear Medicine.